Centroflora CMS Acquires Boehringer Ingelheim's Phytochemical API Portfolio
Centroflora CMS has acquired the phytochemical API product portfolio from Boehringer Ingelheim with the intent to transfer and produce them in order to ensure an uninterrupted market supply. Centroflora CMS has also assumed the exclusive distribution of Centroflora’s Pilocarpine.